// App-Quantinova.ai

LB-269 : Detection of cell-free DNA alterations in AR and its enhancer significantly outperformed CTC AR-V7 detection for identifying treatment resistance in patients with metastatic prostate cancer

Researchers

Presenter

  • Pradeep S. Chauhan

Principal Investigators

  • Ha X. Dang

  • Haley Ellis

  • Wenjia Feng

  • Peter K. Harris

  • Grace Smith

  • Mark Qiao

  • Katherine Dienstbach

  • Rachel Beck

  • Andrew Atkocius

  • Faridi Qaium

  • Jingqin Luo

  • Jeff M. Michalski

  • Joel Picus

  • Russell K. Pachynski

  • Christopher A. Maher

  • Aadel A. Chaudhuri

Medical Centers

  • Washington University School of Medicine, St. Louis, MO

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Androgen receptor variant 7

  • Circulating tumor cells

Drug/Treatment

  • Androgen Tear

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved